FutureMeds Glasgow McCafferty House

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Pfizer2 trials

Running trials

• Active, not recruiting

  A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

  NCT07400653· Phase 3· Pfizer· Source

• Active, not recruiting

  Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

  NCT07311850· Phase 3· Pfizer· Source